Thymosin Beta-4

Also known as: TB4, Timbetasin

Healing & RecoveryPHASE 2

Clinical Status

Phase 2 clinical trials for wound healing and cardiac repair.

Mechanism of Action

Full-length 43-amino-acid protein that sequesters G-actin, promotes cell migration, reduces inflammation, and activates cardiac progenitor cells. Key mediator of tissue repair cascades.

Dosing Defaults

Dose

1-5 mg

Frequency

2-3x weekly

Administration

Subcutaneous or intramuscular injection

Timing

Morning

Food

with or without

Duration

4-12 weeks

Dose range: 1-10 mg per week

Morning dosing supports daytime tissue repair processes.

Side Effects

•Injection site reactions
•Fatigue
•Headache
•Nausea
•Potential concern for tumor promotion

Contraindications & Warnings

⚠Active cancer or cancer history

•Not medical advice
•FDA Category 2

Compare

Compare Thymosin Beta-4 with another peptide side-by-side.

Calculate Dose

Use the reconstitution calculator to prepare your Thymosin Beta-4 dose.

Open Calculator

Related Healing & Recovery Peptides

BPC-157

PRECLINICAL

Healing & Recovery

Synthetic peptide derived from human gastric juice. Known for tissue healing properties.

TB-500

PRECLINICAL

Healing & Recovery

Synthetic fragment of Thymosin Beta-4 used for tissue repair and recovery.

Pentadecapeptide

PRECLINICAL

Healing & Recovery

Research peptide studied for wound healing and tissue regeneration.

GHK

PHASE 2

Healing & Recovery

Naturally occurring tripeptide for tissue remodeling without the copper component.

This information is for educational purposes only and is not medical advice. Dosing data is based on research literature and community reports. Always consult a qualified healthcare provider before using any peptide.